The invention provides a Chinese medicine for curing hepatitis B.
2
目的:评价中药复合制剂乙肝康对慢性乙型肝炎治疗作用。
Objective: To evaluate the clinical therapeutic outcomes of Yigankang in treatment chronic hepatitis B patients.
3
目的研究中药制剂达美施乙肝三号治疗乙肝后肝纤维化、肝硬化的治疗效果及安全性。
Objective To evaluate the efficiency and safety of "TINMAX" HB-3 Herbal Compound (cpd) in treatment of hepatofibrosis and cirrhosis post chronic hepatitis B.